Real-world Evaluation of Health-related Quality of Life in Patients with Multiple Myeloma from Germany
Risk of Disease Recurrence and Survival in Patients with Multiple Myeloma: A German Study Group Analysis Using a Conditional Survival Approach with Long-term Follow-up of 815 Patients
Proteasome Inhibition: the Dawn of Novel Therapies in Multiple Myeloma
Kinetics of Renal Function During Induction in Newly Diagnosed Multiple Myeloma: Results of Two Prospective Studies by the German Myeloma Study Group DSMM
Clinical Characteristics and Outcome of Multiple Myeloma Patients with Concomitant COVID-19 at Comprehensive Cancer Centers in Germany
Validation of the Revised Myeloma Comorbidity Index and Other Comorbidity Scores in a Multicenter German Study Group Multiple Myeloma Trial
Compliance with Vaccination Recommendations Among Patients with Multiple Myeloma: a Real World Experience
From Transplant to Novel Cellular Therapies in Multiple Myeloma
Prevention and Management of Adverse Events of Novel Agents in Multiple Myeloma: a Consensus of the European Myeloma Network
Safe and Successful CAR T-cell Therapy Targeting BCMA in a Multiple Myeloma Patient Requiring Hemodialysis
Olaptesed Pegol, an Anti-CXCL12/SDF-1 Spiegelmer, Alone and with Bortezomib-dexamethasone in Relapsed/refractory Multiple Myeloma: a Phase IIa Study
Allogeneic Transplantation of Multiple Myeloma Patients May Allow Long-term Survival in Carefully Selected Patients with Acceptable Toxicity and Preserved Quality of Life
Covid-19 in Patients with Hematological and Solid Cancers at a Comprehensive Cancer Center in Germany
Correction To: Prognostic Factors for Survival After Allogeneic Transplantation in Acute Lymphoblastic Leukemia
Osteoprotective Medication in the Era of Novel Agents
Cardiovascular Adverse Events in Modern Myeloma Therapy - Incidence and Risks. A Review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)
Dapsone-induced Hemolytic Anemia in Multiple Myeloma: Case Report of Various Differential Diagnoses
The Clinical Relevance and Management of Monoclonal Gammopathy of Undetermined Significance and Related Disorders: Recommendations from the European Myeloma Network
Pomalidomide, Bortezomib, and Dexamethasone for Multiple Myeloma Previously Treated with Lenalidomide (OPTIMISMM): Outcomes by Prior Treatment at First Relapse
Prognostic Factors for Survival After Allogeneic Transplantation in Acute Lymphoblastic Leukemia